EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Medical, Surgical, and Interventional Management of Hypertrophic Cardiomyopathy

Daniele Massera iD, Mark V Sherrid iD, Joshua A Scheinerman, Daniel G Swistel iD, Louai Razzouk iD

Circulation: Cardiovascular Interventions · 2025

DOI: 10.1161/circinterventions.124.014023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Daniele Massera und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hypertrophic Cardiomyopathy Program (D.M., M.V.S., L.R.), Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Cardiac Surgical Procedures, Cardiovascular Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy is a common but underrecognized cardiac disorder characterized by a heterogenous phenotype that includes increased left ventricular thickness, outflow obstruction, diastolic dysfunction, and arrhythmia. Hypertrophic cardiomyopathy is often heritable and associated with pathogenic variants in sarcomeric genes. While not curable, an integrated approach involving medical, interventional, and surgical care can have a considerable impact on disease burden, quality of life, and mortality. This review provides a practical overview of important topics in hypertrophic cardiomyopathy, including evaluation of differential diagnosis, imaging, provocation of left ventricular outflow obstruction, treatment of obstructive and nonobstructive hypertrophic cardiomyopathy with negative inotropic therapy and myosin inhibition, as well as surgical and interventional approaches to septal reduction and mitral valve intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicCardiac Surgical ProceduresCardiovascular AgentsHumansTreatment OutcomeVentricular Outflow ObstructionPhenotypeVentricular Function, LeftPredictive Value of TestsRisk FactorsRecovery of Function

Stichwörter der Autor:innen

adultscardiac surgeryhumanshypertrophic cardiomyopathyventricular outflow obstruction

Substanzen

Cardiovascular Agents

Autor:innen und Institutionen

  • Hypertrophic Cardiomyopathy Program (D.M., M.V.S., L.R.), Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY.
  • Leon H. Charney Division of Cardiology (J.A.S., D.G.S.), Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY.

ORCID-Profile: Daniele Massera, Mark V Sherrid, Daniel G Swistel, Louai Razzouk

Zitieren

APA

Massera, D., Sherrid, M. V., Scheinerman, J. A., Swistel, D. G., & Razzouk, L. (2025). Medical, Surgical, and Interventional Management of Hypertrophic Cardiomyopathy. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.124.014023

Vancouver

Massera D, Sherrid MV, Scheinerman JA, Swistel DG, Razzouk L. Medical, Surgical, and Interventional Management of Hypertrophic Cardiomyopathy. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.124.014023

BibTeX
@article{Massera2025,
  author = {Massera, Daniele and Sherrid, Mark V and Scheinerman, Joshua A and Swistel, Daniel G and Razzouk, Louai},
  title = {Medical, Surgical, and Interventional Management of Hypertrophic Cardiomyopathy},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1161/circinterventions.124.014023}
}
Kostenlos starten →